JPH05507475A - ロイコトリエン関連疾患治療用安息香酸誘導体 - Google Patents

ロイコトリエン関連疾患治療用安息香酸誘導体

Info

Publication number
JPH05507475A
JPH05507475A JP91509448A JP50944891A JPH05507475A JP H05507475 A JPH05507475 A JP H05507475A JP 91509448 A JP91509448 A JP 91509448A JP 50944891 A JP50944891 A JP 50944891A JP H05507475 A JPH05507475 A JP H05507475A
Authority
JP
Japan
Prior art keywords
aliphatic group
compound according
group
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91509448A
Other languages
English (en)
Japanese (ja)
Inventor
デイニーズ，ロバート・エイ
キングスベリー，ウイリアム・デニス
ペンドラク，イスライル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPH05507475A publication Critical patent/JPH05507475A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP91509448A 1990-06-07 1991-05-15 ロイコトリエン関連疾患治療用安息香酸誘導体 Pending JPH05507475A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07
US534.388 1990-06-07
PCT/US1991/003399 WO1991018880A1 (fr) 1990-06-07 1991-05-15 Derives d'acide benzoique utilises dans le traitement de maladies associees au leucotriene

Publications (1)

Publication Number Publication Date
JPH05507475A true JPH05507475A (ja) 1993-10-28

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91509448A Pending JPH05507475A (ja) 1990-06-07 1991-05-15 ロイコトリエン関連疾患治療用安息香酸誘導体

Country Status (16)

Country Link
EP (1) EP0532550A1 (fr)
JP (1) JPH05507475A (fr)
KR (1) KR930700445A (fr)
CN (1) CN1058016A (fr)
AU (1) AU7901791A (fr)
CA (1) CA2083958A1 (fr)
FI (1) FI925544L (fr)
HU (1) HUT64748A (fr)
IE (2) IE911913A1 (fr)
IL (1) IL98388A0 (fr)
MA (1) MA22196A1 (fr)
MX (1) MX26142A (fr)
PL (1) PL290586A1 (fr)
PT (1) PT97912A (fr)
WO (1) WO1991018880A1 (fr)
ZA (1) ZA914323B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022285A1 (fr) * 1992-05-01 1993-11-11 Smithkline Beecham Corporation Antagonistes de leucotrienes
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
EP0649408A4 (fr) 1992-06-30 1995-06-21 Smithkline Beecham Corp Procede de production de phenylthiomethylpyridinylalcenoates.
EP0675718A1 (fr) * 1992-12-23 1995-10-11 Smithkline Beecham Corporation Composes de pyridyle a substitution utiles comme antagonistes des leucotrienes
EP0733044A4 (fr) * 1993-12-08 1997-03-05 Smithkline Beecham Corp Composes
WO1995028386A1 (fr) * 1994-04-13 1995-10-26 F. Hoffmann-La Roche Ag Antagonistes des leucotrienes b4 a substitution pyridine
CN100456944C (zh) * 2001-03-27 2009-02-04 明治制果株式会社 膨化小食品的制造方法及其制造装置
DK2520654T3 (en) 2003-08-26 2017-05-01 Univ Colorado Regents Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
AU7901791A (en) 1991-12-31
HUT64748A (en) 1994-02-28
HU9203866D0 (en) 1993-03-29
WO1991018880A1 (fr) 1991-12-12
KR930700445A (ko) 1993-03-15
MA22196A1 (fr) 1992-04-01
FI925544A0 (fi) 1992-12-07
PL290586A1 (en) 1992-04-06
PT97912A (pt) 1992-03-31
IL98388A0 (en) 1992-07-15
CA2083958A1 (fr) 1991-12-08
FI925544A7 (fi) 1992-12-07
IE911912A1 (en) 1991-12-18
FI925544L (fi) 1992-12-07
ZA914323B (en) 1992-06-24
EP0532550A1 (fr) 1993-03-24
MX26142A (es) 1994-02-28
IE911913A1 (en) 1991-12-18
CN1058016A (zh) 1992-01-22

Similar Documents

Publication Publication Date Title
DE602004006631T2 (de) Matrix metalloprotease inhibitoren
DE60215699T2 (de) Quinolinone als prostaglandin rezeptor liganden
DE69732966T2 (de) Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) des typs iv und der produktion des tumor nekrosis faktors (tnf)
DE69926542T2 (de) Aminopyrazolderivate
DE69118388T2 (de) Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
JP2019011352A (ja) トロンビンの阻害剤としての多置換芳香族化合物
JP2002522541A (ja) ホスホジエステラーゼ４阻害剤としての置換１，８−ナフチリジン−４（１ｈ）−オン
JP2007524682A (ja) 代謝調節型グルタミン酸受容体−５の調節物質としてのビピリジルアミド
JP2005508948A (ja) 選択性の優れたシクロオキシゲナーゼ−２の阻害剤としての１ｈ−インドール誘導体
DE69709493T2 (de) Substituierte Indazolderivate
JPH11505236A (ja) フェニルジヒドロベンゾフラン
DE3522579C2 (de) Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben
JPH01301661A (ja) 新規ピリジル誘導体
JPH06510786A (ja) ロイコトリエン関連疾患治療用ピリジン化合物
JPH05507492A (ja) 安息香酸誘導体
IE911913A1 (en) Benzoic acid derivatives for treating leukotriene-related¹diseases
JP3230682B2 (ja) 医薬ピリジン化合物
JPH03163074A (ja) フラン誘導体
ES2391371T3 (es) Derivados de la 2-trifluorometilnicotinamida como agentes para aumentar el HDL-colesterol
US4783473A (en) Geminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of use
JPH05507701A (ja) ロイコトリエン関連疾患治療用フタルアミド酸およびその異性体
JPH05507698A (ja) ロイコトリエン関連疾患治療用アミド結合ピリジル―安息香酸誘導体
FR2911605A1 (fr) Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
WO1998058930A1 (fr) Composes de triazolo-1,4-diazepine et composition medicinale les contenant
US4131677A (en) Anti-inflammatory oxazolo [5,4-b]pyridines